Quality of Life Appears to Suffer Little When Adding Radiation to Androgen Deprivation for Prostate Cancer Quality of Life Appears to Suffer Little When Adding Radiation to Androgen Deprivation for Prostate Cancer

Patients with low-volume metastatic prostate cancer (mPCa) receiving androgen-deprivation therapy (ADT) only temporarily experience more bowel and urinary symptoms when EBRT is added to their treatment, according to new findings from the HORRAD trial.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news